These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 38618967)
21. Tumor suppressor function of RBMS3 overexpression in EOC associated with immune cell infiltration. Yin T; Zhang Y; Zhao Y; Zhang X; Han S; Wang Y; Yang B Heliyon; 2024 May; 10(9):e30603. PubMed ID: 38726149 [TBL] [Abstract][Full Text] [Related]
22. Low expression of RBMS3 and SFRP1 are associated with poor prognosis in patients with gastric cancer. Zhang T; Wu Y; Fang Z; Yan Q; Zhang S; Sun R; Khaliq J; Li Y Am J Cancer Res; 2016; 6(11):2679-2689. PubMed ID: 27904780 [TBL] [Abstract][Full Text] [Related]
23. Rbms3 functions in craniofacial development by posttranscriptionally modulating TGF-β signaling. Jayasena CS; Bronner ME J Cell Biol; 2012 Oct; 199(3):453-66. PubMed ID: 23091072 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene. He X; Dong Y; Wu CW; Zhao Z; Ng SS; Chan FK; Sung JJ; Yu J Mol Med; 2013 Feb; 18(1):1491-8. PubMed ID: 23255074 [TBL] [Abstract][Full Text] [Related]
25. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. Zheng X; Wang Q; Zhou Y; Zhang D; Geng Y; Hu W; Wu C; Shi Y; Jiang J Cancer Commun (Lond); 2022 Dec; 42(12):1347-1366. PubMed ID: 36209353 [TBL] [Abstract][Full Text] [Related]
26. RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma. Liang YN; Liu Y; Meng Q; Li X; Wang F; Yao G; Wang L; Fu S; Tong D Med Oncol; 2015 Feb; 32(2):459. PubMed ID: 25588924 [TBL] [Abstract][Full Text] [Related]
27. Downregulation of RBMS3 is associated with poor prognosis in esophageal squamous cell carcinoma. Li Y; Chen L; Nie CJ; Zeng TT; Liu H; Mao X; Qin Y; Zhu YH; Fu L; Guan XY Cancer Res; 2011 Oct; 71(19):6106-15. PubMed ID: 21844183 [TBL] [Abstract][Full Text] [Related]
28. Translation inhibition during cell cycle arrest and apoptosis: Mcl-1 is a novel target for RNA binding protein CUGBP2. Subramaniam D; Natarajan G; Ramalingam S; Ramachandran I; May R; Queimado L; Houchen CW; Anant S Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G1025-32. PubMed ID: 18292181 [TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA CCAT1/miR-218/ZFX axis modulates the progression of laryngeal squamous cell cancer. Zhang Y; Hu H Tumour Biol; 2017 Jun; 39(6):1010428317699417. PubMed ID: 28631575 [TBL] [Abstract][Full Text] [Related]
30. RBMS3 delays disc degeneration by inhibiting Wnt/β-catenin signaling pathway. Wang JJ; Liu XY; Du W; Liu JQ; Sun B; Zheng YP Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):499-507. PubMed ID: 32016951 [TBL] [Abstract][Full Text] [Related]
31. Rbms3, an RNA-binding protein, mediates the expression of Ptf1a by binding to its 3'UTR during mouse pancreas development. Lu CK; Lai YC; Chen HR; Chiang MK DNA Cell Biol; 2012 Jul; 31(7):1245-51. PubMed ID: 22372950 [TBL] [Abstract][Full Text] [Related]
32. Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer via Activation of miR-126-5p/β-catenin/CBP signaling. Wu G; Cao L; Zhu J; Tan Z; Tang M; Li Z; Hu Y; Yu R; Zhang S; Song L; Li J Clin Cancer Res; 2019 Feb; 25(3):1022-1035. PubMed ID: 30279231 [TBL] [Abstract][Full Text] [Related]
33. Comprehensive Analyses and Immunophenotyping of LIM Domain Family Genes in Patients with Non-Small-Cell Lung Cancer. Li S; Liu L; Qu Y; Yuan L; Zhang X; Ma Z; Bai H; Wang J Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901953 [TBL] [Abstract][Full Text] [Related]
34. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
35. miR‑4262 inhibits colon cancer cell proliferation via targeting of GALNT4. Qu JJ; Qu XY; Zhou DZ Mol Med Rep; 2017 Oct; 16(4):3731-3736. PubMed ID: 28731150 [TBL] [Abstract][Full Text] [Related]
36. Role of RBMS3 Novel Potential Regulator of the EMT Phenomenon in Physiological and Pathological Processes. Górnicki T; Lambrinow J; Mrozowska M; Podhorska-Okołów M; Dzięgiel P; Grzegrzółka J Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142783 [TBL] [Abstract][Full Text] [Related]
37. miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1. Zeng M; Zhu L; Li L; Kang C Cell Mol Biol Lett; 2017; 22():12. PubMed ID: 28725241 [TBL] [Abstract][Full Text] [Related]
38. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3. Yi J; Peng F; Zhao J; Gong X Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232 [TBL] [Abstract][Full Text] [Related]
39. Over-Expression of MicroRNA-122 Inhibits Proliferation and Induces Apoptosis in Colon Cancer Cells. Malayaperumal S; Sriramulu S; Banerjee A; Pathak S Microrna; 2020; 9(5):354-362. PubMed ID: 33297929 [TBL] [Abstract][Full Text] [Related]
40. Circular RNA circCSPP1 promotes the occurrence and development of colon cancer by sponging miR-431 and regulating ROCK1 and ZEB1. Wang J; Zhou L; Chen B; Yu Z; Zhang J; Zhang Z; Hu C; Bai Y; Ruan X; Wang S; Ouyang J; Wu A; Zhao X J Transl Med; 2022 Jan; 20(1):58. PubMed ID: 35101080 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]